Ekso Bionics Holdings, Inc. (EKSO)

Market Cap	19.45M
Revenue (ttm)	13.44M
Net Income (ttm)	-14.77M
Shares Out	13.14M
EPS (ttm)	-1.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,007
Open	1.49
Previous Close	1.54
Day's Range	1.46 - 1.54
52-Week Range	1.03 - 2.95
Beta	1.76
Analysts	Buy
Price Target	9.18 (+520.27%)
Earnings Date	Apr 26, 2023

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provide...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 55
• Stock Exchange: NASDAQ
• Ticker Symbol: EKSO

Financial Performance

In 2021, EKSO's revenue was $11.25 million, an increase of 26.62% compared to the previous year's $8.88 million. Losses were -$9.76 million, -38.30% less than in 2020.

Analyst Forecast

According to 7 analysts, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is $9.18, which is an increase of 520.27% from the latest price.

Price Target

$9.18

(520.27% upside)

Analyst Consensus: Buy